CONCORD DRUGS LTD.

NSE : NABSE : 538965ISIN CODE : INE858L01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE27.01-0.98 (-3.5 %)

PREV CLOSE ( ) 27.99

OPEN PRICE ( ) 27.99

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3474

TODAY'S LOW / HIGH ( )27.00 28.50

52 WK LOW / HIGH ( ) 19.541.65

NSE

This Company is not listed in NSE

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995

Management Info

S Nagi Reddy - Chairman S Nagi Reddy - Managing Director

Registered Office

Address Survey No.249, Brahmanapally Village,Hayatnagar Mandal, ,
Rangareddy Dist,
Telangana-501511

Phone 09052779505

Email concorddrugsltd@gmail.com

Website www.concorddrugs.in

Registrars Details

Aarthi Consultants Pvt Ltd

1-2-285 ,Domalaguda,,Hyderabad

Listing : BSE, Ahmedabad

NEWS

16Mar Allotment of Equity Shares
Inter alia, to consider and approve:- 1. Conversion of warrants into eq..

08Sep Concord Drugs gets nod to acquire enti
Concord Drugs has received approval to acquire upto 100% stake in Proton..

08Sep Concord Drugs jumps on getting nod to
Concord Drugs is currently trading at Rs. 35.80, up by 1.85 points or 5...

02Jun Concord Drugs informs about outcome of
Concord Drugs has informed the exchange that at the Board meeting held o..

16Nov Concord Drugs informs about disclosures
Concord Drugs has informed that the exchange has received the disclosure..

Financials

in Millions

	QTR Dec 22	ANNUAL 22
Net Profit	4.53999999999999	15.9400000000001
Gross Profit	6.15999999999999	22.4800000000001
Operating Profit	14.45	56.9400000000001
Net Sales	135.28	590.57

EVENT CALENDAR

peer group

Gland Pharma (BSE) 1231.75 (5.84%)	M.Cap ( in Cr)20285.72
Natural Capsules (BSE) 432.30 (9.54%)	M.Cap ( in Cr)404.16
AMI Organics (BSE) 934.50 (3.72%)	M.Cap ( in Cr)3405.04
RPG Life Sciences (BSE) 746.60 (4.65%)	M.Cap ( in Cr)1234.80
Ajanta Pharma (BSE) 1206.80 (2.01%)	M.Cap ( in Cr)15462.14

	NON-INSTITUTION	51%
	PROMOTERS	49%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Scheme Name	Hold(%)
No Data Found

About Concord Drugs Ltd.

Concord Drugs Ltd. was incorporated in the year 1995. Its today's share price is 27.01. Its current market capitalisation stands at Rs 23.62 Cr. In the latest quarter, company has reported Gross Sales of Rs. 589.56 Cr and Total Income of Rs.590.57 Cr. The company's management includes Ankur Bisht, Sumeela, K Ramachandra Reddy, S Nagavenkata Hareesh, S Manoj Kumar Reddy, S Koni Reddy, S Nagi Reddy, S Nagi Reddy.

It is listed on the BSE with a BSE Code of 538965 , NSE with an NSE Symbol of and ISIN of INE858L01010. It's Registered office is at Survey No.249, Brahmanapally Village,Hayatnagar Mandal, Rangareddy Dist-501511, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are MM Reddy & Co, NG Rao & Associates, Pundarikashyam & Associates

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances NPS Grievance Policy SEBI Scores RMS Policy Inspection CSR Committee CSR Policy

CSR Activities

FY-2020-2021 FY-2021-2022 FY-2022-2023

Investor Charter

Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Evoting

NSDL Evoting CDSL Evoting

Client Bank Account list

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote